---
title: "Lilly expects Q2 acquired IPR&D charge of about $2.8 billion pretax, $3.02/sh hit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292112302.md"
description: "Eli Lilly anticipates a $2.8 billion pre-tax acquired IPR&D charge in Q2 2026, driven by costs from collaborations and asset acquisitions. This charge is expected to reduce both GAAP and non-GAAP earnings per share by approximately $3.02."
datetime: "2026-07-08T20:33:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292112302.md)
  - [en](https://longbridge.com/en/news/292112302.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292112302.md)
generator: "portal-rs"
---

# Lilly expects Q2 acquired IPR&D charge of about $2.8 billion pretax, $3.02/sh hit

-   Eli Lilly expects Q2 2026 acquired IPR&D charges of about USD 2.8 billion on a pre-tax basis. \* The charge is forecast to cut both GAAP and non-GAAP EPS by about USD 3.02. \* The estimate reflects anticipated costs tied to collaborations, licensing deals, or other asset acquisitions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eli Lilly and Company published the original content used to generate this news brief on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)

## Related News & Research

- [Why Is Omniab Stock Rallying After Eli Lilly Deal?](https://longbridge.com/en/news/296113651.md)
- [Eli Lilly Is Building a Weight Loss Drug for Every Kind of Patient](https://longbridge.com/en/news/296005917.md)
- [Sarasin & Partners LLP Sells 11,349 Shares of Eli Lilly and Company $LLY](https://longbridge.com/en/news/295214848.md)
- [LLY: Q2 2026 revenue surged 48% to $23B, driving raised full-year guidance and robust pipeline progress](https://longbridge.com/en/news/294955478.md)
- [Community Financial Services Group LLC Acquires 1,774 Shares of Eli Lilly and Company $LLY](https://longbridge.com/en/news/295504105.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**